Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “2019-nCoV Pneumonia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT04353128
What this trial is testing

Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers.

Who this might be right for
Covid19SARS-CoV 2Coronavirus Infection
Instituto de Investigación Hospital Universitario La Paz 450
Not applicableEnded earlyNCT04902911
What this trial is testing

Point of Care Evaluation of Novir 2019-nCoV Immunoglobulin G/ Immunoglobulin M (IgG/IgM) Antibody Test (Collodial Gold)

Who this might be right for
Covid19
Medical College of Wisconsin 91
Not applicableStudy completedNCT04378777
What this trial is testing

Immunophenotyping Assessment in a COVID-19 Cohort

Who this might be right for
Coronavirus Disease 2019 (COVID-19)SARS-CoV-2
National Institute of Allergy and Infectious Diseases (NIAID) 1,227
Large-scale testing (Phase 3)Ended earlyNCT04511819
What this trial is testing

Losmapimod Safety and Efficacy in COVID-19

Who this might be right for
COVID-19
Fulcrum Therapeutics 52
Large-scale testing (Phase 3)Study completedNCT05107375
What this trial is testing

Clinical Study of Recombinant Novel Coronavirus（COVID-19） Vaccine (CHO Cell) Combined With Influenza Vaccine

Who this might be right for
Coronavirus Disease 2019
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 299
Not applicableActive Not RecruitingNCT05160636
What this trial is testing

Look at the Health Outcomes of Patients With COVID-19 and Influenza

Who this might be right for
COVID-19Coronavirus Disease 2019Influenza
Pfizer 999
Not applicableUnknownNCT04747366
What this trial is testing

Analysis of the Pathophysiology and Pathology of Coronavirus Disease 2019 (COVID-19), Including Chronic Morbidity

Who this might be right for
Covid19
Charite University, Berlin, Germany 750
Testing effectiveness (Phase 2)Study completedNCT04771013
What this trial is testing

Safety and Efficacy of Thymic Peptides in the Treatment of Hospitalized COVID-19 Patients in Honduras

Who this might be right for
COVID-19
Universidad Católica de Honduras 22
Testing effectiveness (Phase 2)UnknownNCT05113810
What this trial is testing

The Potential Use of Nebulized Hydroxychloroquine for the Treatment of COVID-19

Who this might be right for
2019 Novel Coronavirus
Ministry of Health Jordan 110
Early research (Phase 1)Study completedNCT04523571
What this trial is testing

Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b1) in Chinese Healthy Subjects

Who this might be right for
SARS-CoV-2
BioNTech SE 144
Not applicableStudy completedNCT04545047
What this trial is testing

Observational Study of Convalescent Plasma for Treatment of Veterans With COVID-19

Who this might be right for
Coronavirus Disease 2019 (COVID-19)
VA Office of Research and Development 5,044
Testing effectiveness (Phase 2)Ended earlyNCT04458298
What this trial is testing

Evaluate OP-101 (Dendrimer N-acetyl-cysteine) in Severe Coronavirus Disease 2019 (COVID-19) Patients

Who this might be right for
COVID-19
Ashvattha Therapeutics, Inc. 28
Early research (Phase 1)Study completedNCT04988152
What this trial is testing

Investigate the PK, Safety, and Tolerability of Sotrovimab vs Placebo Administered IV or IM in Japanese and Caucasian Participants

Who this might be right for
Covid19
Vir Biotechnology, Inc. 48
Testing effectiveness (Phase 2)Study completedNCT04649021
What this trial is testing

Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b2) in Chinese Healthy Population

Who this might be right for
SARS-CoV-2
BioNTech SE 960
Not applicableStudy completedNCT04351503
What this trial is testing

A Systems Approach to Predict the Outcome of SARS-CoV-2 in the Population of a City; COVID-19

Who this might be right for
SARS Coronavirus (SARS-CoV-2) Infection
University Hospital, Basel, Switzerland 126,586
Not applicableWithdrawnNCT04285190
What this trial is testing

The Effect of T89 on Improving Oxygen Saturation and Clinical Symptoms in Patients With COVID-19

Who this might be right for
Coronavirus Disease 2019Novel Coronavirus Pneumonia
Tasly Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Study completedNCT05438602
What this trial is testing

Learn About the Study Medicines (Nirmatrelvir Plus Ritonavir) in People Aged 12 Years or Older With COVID-19 and a Compromised Immune System

Who this might be right for
COVID-19
Pfizer 158
Not applicableStudy completedNCT05089045
What this trial is testing

Immunogenicity and Safety Evaluation of Recombinant Novel Coronavirus Vaccine (CHO Cells) in Enhancing Immunity

Who this might be right for
Coronavirus Disease 2019
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 360
Not applicableStudy completedNCT05594147
What this trial is testing

An Observational Study, Called ROCURS, to Learn About COVID-19 Related Outcomes in People With Cancer Who Are Treated With Tyrosine Kinase Inhibitors (TKIs) Including Regorafenib or Sorafenib

Who this might be right for
Malignant Solid TumorsCoronavirus Disease 2019 (COVID-19)SARS-CoV-2 Infection
Bayer 4,103
Testing effectiveness (Phase 2)Study completedNCT04346199
What this trial is testing

Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.

Who this might be right for
COVID-19
AstraZeneca 177
Next Page